The mildly elevated serum bilirubin level is negatively associated with the incidence of end stage renal disease in patients with IgA nephropathy

Journal of Korean Medical Science

Volumn 24, Issue , 2009, Pages S22-S29

  Chin, Ho Jun ^a,b   Cho, Hyun Jin ^a   Lee, Tae Woo ^b   Na, Ki Young ^a,b   Oh, Kook Hwan ^b   Joo, Kwon Wook ^b   Yoon, Hyung Jin ^c   Kim, Yon Su ^b   Ahn, Curie ^b   Han, Jin Suk ^b   Kim, Suhnggwon ^b   Jeon, En Sil ^d   Jin, Dong Chan ^e   Kim, Yong Lim ^f   Park, Sun Hee ^f   Kim, Chan Duck ^f   Song, Young Rim ^g   Kim, Seong Gyun ^g   Kim, Yoon Goo ^h   Lee, Jung Eun ^h   Oh, Yoon Kyu ^b   Lim, Chun Soo ^b   Lee, Sang Koo ⁱ   Chae, Dong Wan ^a,b   Cho, Won Yong ^j   Kim, Hyoung Kyu ^j   Jo, Sang Kyung ^j   Jang, Eun Hee ^k   Kim, Won ^l   Kim, Nam Ho ^m   Bae, Woo Kyun ^m   Kim, Hye Young ⁿ   Shin, Young Tai ^o   Lee, Kang Wook ^o   Na, Ki Ryang ^o   Ahn, Ki Sung ^p   Cho, Jong Tae ^q   Lee, Eun Kyeong ^q   Kim, Ki Hyun ^r   An, WonSuk ^r   Kim, Seong Eun ^r   Bog, Choi Gyu ^s   Kim, Seung Jung ^s   Chung, Woo Kyung ^t   Lee, Hyun Hee ^t   Yang, Jaeseok ^t   Kim, Sejoong ^t   Chang, Se Ho ^u   Noh, Jung Woo ^g   Lee, Young Ki ^g   Oh, Jieun ^g   Kim, Moon Jae ^v   Lee, Seoung Woo ^v   Kim, Yeong Hoon ^w   Park, Won Do ^w   Kim, Hyun Chul ^x   Park, Sung Bae ^x   Kim, Kyo Soon ^y   Ryong, Cha Dae ^z   Sun, Kang Young ^z   Kwon, Young Joo ^j   Yang, Dong Ho ^aa   Kwak, Ihm Soo ^ab   Lee, Soo Bong ^ab   Lee, Dong Won ^ab   Song, Sang Heon ^ab   Seoung, Eun Young ^ab   Yoon, Su Jin ^ac   Lee, Kyu Beck ^h   Do, Jun Young ^ad   Park, Jong Won ^ad   Yoon, Kyung Woo ^ad   more..

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Biomedical Research Institute   (South Korea)

^d Pohang University of Science and Technology (POSTECH)   (South Korea)

^e The Catholic University of Korea College of Medicine   (South Korea)

^f Kyungpook National University School of Medicine   (South Korea)

^g Hallym University College of Medicine   (South Korea)

^h Sungkyunkwan University School of Medicine   (South Korea)

ⁱ University of Ulsan College of Medicine   (South Korea)

^j Korea University College of Medicine   (South Korea)

^k Jeju National University   (South Korea)

^l Chonbuk National University Medical School   (South Korea)

^m Chonnam National University Medical School   (South Korea)

ⁿ Chungbuk National University College of Medicine   (South Korea)

^o Chungnam National University College of Medicine   (South Korea)

^p Catholic University of Daegu   (South Korea)

^q Dankook University   (South Korea)

^r Dong A University College of Medicine   (South Korea)

^s Ewha Womans University School of Medicine   (South Korea)

^t Gachon University College of Medicine   (South Korea)

^u Gyeongsang National University   (South Korea)

^v Inha University School of Medicine   (South Korea)

^w Inje University College of Medicine   (South Korea)

^x Keimyung University School of Medicine   (South Korea)

^y Konkuk University School of Medicine   (South Korea)

^z Korea University   (South Korea)

^aa CHA University   (South Korea)

^ab Pusan National University School of Medicine   (South Korea)

^ac Seoul Medical Center   (South Korea)

^ad Yeungnam University College of Medicine   (South Korea)

more..

Author keywords

Bilirubin; Chronic; Glomerulonephritis; IGA; Kidney Failure

Indexed keywords

BILIRUBIN;

ADULT; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; MALE; MIDDLE AGED; RISK; RISK FACTOR; TREATMENT OUTCOME;

ADULT; BILIRUBIN; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RISK; RISK FACTORS; TREATMENT OUTCOME;

EID: 62449126418     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.S1.S22     Document Type: Article

References (30)

1. Donadio JV, Grande JP. IgA nephropathy. New Engl J Med 2002; 347: 738-48.
2. Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol 2005; 16: 2088-97.
3. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, Cardoso C, Noel LH, Guerin AP, London GM, Jungers P. Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. Kidney Int 2004; 66: 1606-12.
4. Kobori H, Katsurada A, Ozawa Y, Satou R, Miyata K, Hase N, Suzaki Y, Shoji T. Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. Biochem Biophys Res Commun 2007; 358: 156-63.
5. Chen HC, Tomino Y, Yaguchi Y, Fukui M, Yokoyama K, Watanabe A, Koide H. Oxidative metabolism of polymorphonuclear leukocytes (PMN) in patients with IgA nephropathy. J Clin Lab Anal 1992; 6: 35-9.
6. Turi S, Nemeth I, Torkos A, Saghy L, Varga I, Matkovics B, Nagy J. Oxidative stress and antioxidant defense mechanism in glomerular disease. Free Rad Biol Med 1997; 22: 161-8.
7. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-6.
8. Lanone S, Bloc S, Foresti R, Almolki A, Taille C, Callebert J, Conti M, Goven D, Aubier M, Dureuil B, El-Benna J, Motterlini R, Boczkowski J. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 2005; 19: 1890-2.
9. Sano K, Nakamura H, Matsuo T. Mode of inhibitory action of bilirubin on protein kinase C. Pediatr Res 1985; 19: 587-90.
10. Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 2003; 228: 568-71.
11. Endler G, Hamwi A, Sunder-Plassmann R, Exner M, Vukovich T, Mannhalter C, Wojta J, Huber K, Wagner O. Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women? Clin Chem 2003; 49: 1201-4.
12. Pflueger A, Croatt AJ, Peterson TE, Smith LA, d'Uscio LV, Katusic ZS, Nath KA. The hyperbilirubinemic Gunn rat is resistant to the pressor effects of angiotensin II. Am J Physiol Renal Physiol 2005; 288: F552-8.
13. Adin CA, Croker BP, Agarwal A. Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney. Am J Phyisol Renal Physiol 2005; 288: F778-84.
14. Kirkby K, Baylis C, Agarwal A, Croker B, Archer L, Adin C. Intravenous bilirubin provides incomplete protection against renal ischemia-reperfusion injury in vivo. Am J Physiol Renal Physiol 2007; 292: F888-94.
15. Nakao A, Neto JS, Kanno S, Stolz DB, Kimizuka K, Liu F, Bach FH, Billiar TR, Choi AM, Otterbein LE, Murase N. Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 2005; 5: 282-91.
16. Manolio TE, Burke GL, Savage PJ, Jacobs DR Jr, Sidney S, Wagenknecht LE, Allman RM, Tracy RP. Sex-and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin Chem 1992; 38: 1853-9.
17. Schmid R, Diamond I, Hammaker L, Gundersen CB. Interaction of bilirubin with albumin. Nature 1965; 206: 1041-3.
18. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-100.
19. Kim SY, Jin DC, Bang BK. Current status of dialytic therapy in Korea. Nephrology (Carlton) 2003; 8 (Suppl): S2-9.
20. Lee SW, Park GH, Lee SY, Song JH, Kim MJ. Comparison of anthropometric data between end-stage renal disease patients undergoing hemodialysis and healthy adults in Korea. Yonsei Med J 2005; 46: 658-66.
21. Moranne O, Watier L, Rossert J, Stengel B; GN-Progress Study Group. Primary glomerulonephritis: an update on renal survival and determinants of progression. QJM 2008; 101: 215-24.
22. Ibels LS, Gyory AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1994; 73: 79-102.
23. Radford MG, Donadio JV, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997; 8: 199-207.
24. Li JM, Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 2003; 14 (8 Suppl 3): S221-6.
25. Kitada M, Koya D, Sugimoto T, Isono M, Araki S, Kashiwagi A, Haneda M. Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy. Diabetes 2003; 52: 2603-14.
26. Thannickal VJ, Fanburg BL. Activation of an H2O2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J Biol Chem 1995; 270: 30334-8.
27. Sharma K, Cook A, Smith M, Valancius C, Inscho EW. TGF-beta impairs renal autoregulation via generation of ROS. Am J Physiol Renal Physiol 2005; 288: F1069-77.
28. Lin LY, Kuo HK, Hwang JJ, Lai LP, Chiang FT, Tseng CD, Lin JL. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis 2008 Jul 26 [Epub ahead of print].
29. Liu Y, Li P, Lu J, Xiong W, Oger J, Tetzlaff W, Cynader M. Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis. J Immunol 2008; 181: 1887-97.
30. Toth B, Yokoyama Y, Kuebler JF, Schwacha MG, Rue LW 3rd, Bland KI, Chaudry IH. Sex differences in hepatic heme oxygenase expression and activity following trauma and hemorrhagic shock. Arch Surg 2003; 138: 1375-82.